$IBPI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ardea Biosciences, Inc./DE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Ardea Biosciences, Inc./DE. Get notifications about new insider transactions in Ardea Biosciences, Inc./DE for free.
Page: < prev 1 2 3 4 5 6 ... 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 06 2012 | IBPI | Ardea Biosciences, ... | DAVIS STEPHEN | EVP & COO | Payment of Exercise | F | 15.55 | 218 | 3,390 | 16,922 | 17.1 K to 16.9 K (-1.27 %) |
Jan 05 2012 | IBPI | Ardea Biosciences, ... | POYHONEN JOHN | Director | Option Exercise | A | 16.47 | 12,500 | 205,875 | 12,500 | |
Jan 05 2012 | IBPI | Ardea Biosciences, ... | Johnson Craig A | Director | Option Exercise | A | 16.47 | 12,500 | 205,875 | 12,500 | |
Jan 05 2012 | IBPI | Ardea Biosciences, ... | FUCHS HENRY J | Director | Option Exercise | A | 16.47 | 12,500 | 205,875 | 12,500 | |
Jan 05 2012 | IBPI | Ardea Biosciences, ... | DIXON WENDY L | Director | Option Exercise | A | 16.47 | 12,500 | 205,875 | 12,500 | |
Jan 05 2012 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Option Exercise | A | 16.47 | 12,500 | 205,875 | 12,500 | |
Jan 05 2012 | IBPI | Ardea Biosciences, ... | BAKER FELIX | Director | Option Exercise | A | 16.47 | 12,500 | 205,875 | 12,500 | |
Dec 29 2011 | IBPI | Ardea Biosciences, ... | Quart Barry D | President and CEO | Gift | G | 0.00 | 5,000 | 0 | 42,889 | 47.9 K to 42.9 K (-10.44 %) |
Dec 29 2011 | IBPI | Ardea Biosciences, ... | Quart Barry D | President and CEO | Gift | G | 0.00 | 5,000 | 0 | 47,889 | 52.9 K to 47.9 K (-9.45 %) |
Dec 29 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Option Exercise | M | 3.90 | 5,000 | 19,500 | 30,000 | |
Dec 29 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Sell | S | 16.97 | 5,000 | 84,862 | 9,731 | 14.7 K to 9.7 K (-33.94 %) |
Dec 29 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Buy | M | 3.90 | 5,000 | 19,500 | 14,731 | 9.7 K to 14.7 K (+51.38 %) |
Dec 20 2011 | IBPI | Ardea Biosciences, ... | Quart Barry D | President and CEO | Option Exercise | A | 18.94 | 155,000 | 2,935,700 | 155,000 | |
Dec 20 2011 | IBPI | Ardea Biosciences, ... | Quart Barry D | President and CEO | Gift | G | 0.00 | 10,000 | 0 | 52,889 | 62.9 K to 52.9 K (-15.90 %) |
Dec 20 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Option Exercise | A | 18.94 | 40,000 | 757,600 | 40,000 | |
Dec 20 2011 | IBPI | Ardea Biosciences, ... | Hagerty David T | Senior VP & CMO | Option Exercise | A | 18.94 | 33,600 | 636,384 | 33,600 | |
Dec 20 2011 | IBPI | Ardea Biosciences, ... | DAVIS STEPHEN | EVP & COO | Option Exercise | A | 18.94 | 80,000 | 1,515,200 | 80,000 | |
Dec 08 2011 | IBPI | Ardea Biosciences, ... | DAVIS STEPHEN | EVP & COO | Payment of Exercise | F | 19.93 | 191 | 3,807 | 17,140 | 17.3 K to 17.1 K (-1.10 %) |
Nov 29 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Option Exercise | M | 3.90 | 5,000 | 19,500 | 35,000 | |
Nov 29 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Sell | S | 17.67 | 5,000 | 88,357 | 9,731 | 14.7 K to 9.7 K (-33.94 %) |
Nov 29 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Buy | M | 3.90 | 5,000 | 19,500 | 14,731 | 9.7 K to 14.7 K (+51.38 %) |
Nov 17 2011 | IBPI | Ardea Biosciences, ... | DAVIS STEPHEN | EVP & COO | Sell | S | 18.86 | 432 | 8,146 | 17,331 | 17.8 K to 17.3 K (-2.43 %) |
Nov 08 2011 | IBPI | Ardea Biosciences, ... | DAVIS STEPHEN | EVP & COO | Payment of Exercise | F | 18.81 | 191 | 3,593 | 17,187 | 17.4 K to 17.2 K (-1.10 %) |
Oct 28 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Option Exercise | M | 3.90 | 5,000 | 19,500 | 40,000 | |
Oct 28 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Sell | S | 21.27 | 5,000 | 106,374 | 9,387 | 14.4 K to 9.4 K (-34.75 %) |
Oct 28 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Buy | M | 3.90 | 5,000 | 19,500 | 14,387 | 9.4 K to 14.4 K (+53.27 %) |
Oct 07 2011 | IBPI | Ardea Biosciences, ... | DAVIS STEPHEN | EVP & COO | Sell | S | 15.43 | 700 | 10,803 | 17,378 | 18.1 K to 17.4 K (-3.87 %) |
Oct 07 2011 | IBPI | Ardea Biosciences, ... | DAVIS STEPHEN | EVP & COO | Payment of Exercise | F | 15.73 | 191 | 3,004 | 18,078 | 18.3 K to 18.1 K (-1.05 %) |
Sep 30 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Option Exercise | M | 3.90 | 5,000 | 19,500 | 45,000 | |
Sep 30 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Sell | S | 16.28 | 5,000 | 81,423 | 9,387 | 14.4 K to 9.4 K (-34.75 %) |
Sep 30 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Buy | M | 3.90 | 5,000 | 19,500 | 14,387 | 9.4 K to 14.4 K (+53.27 %) |
Aug 30 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Option Exercise | M | 3.90 | 5,000 | 19,500 | 50,000 | |
Aug 30 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Sell | S | 15.13 | 5,000 | 75,634 | 9,387 | 14.4 K to 9.4 K (-34.75 %) |
Aug 30 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Buy | M | 3.90 | 5,000 | 19,500 | 14,387 | 9.4 K to 14.4 K (+53.27 %) |
Sep 07 2011 | IBPI | Ardea Biosciences, ... | DAVIS STEPHEN | EVP & COO | Payment of Exercise | F | 15.46 | 191 | 2,953 | 18,269 | 18.5 K to 18.3 K (-1.03 %) |
Aug 09 2011 | IBPI | Ardea Biosciences, ... | DAVIS STEPHEN | EVP & COO | Payment of Exercise | F | 18.22 | 191 | 3,480 | 18,460 | 18.7 K to 18.5 K (-1.02 %) |
Aug 02 2011 | IBPI | Ardea Biosciences, ... | Johnson Craig A | Director | Option Exercise | M | 12.16 | 1,000 | 12,160 | 9,500 | |
Aug 02 2011 | IBPI | Ardea Biosciences, ... | Johnson Craig A | Director | Sell | S | 23.16 | 1,000 | 23,163 | 0 | 1,000 to 0 (-100.00 %) |
Aug 02 2011 | IBPI | Ardea Biosciences, ... | Johnson Craig A | Director | Buy | M | 12.16 | 1,000 | 12,160 | 1,000 | 0 to 1,000 |
Jul 29 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Option Exercise | M | 3.90 | 5,000 | 19,500 | 55,000 | |
Jul 29 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Sell | S | 23.56 | 5,000 | 117,813 | 9,387 | 14.4 K to 9.4 K (-34.75 %) |
Jul 29 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Buy | M | 3.90 | 5,000 | 19,500 | 14,387 | 9.4 K to 14.4 K (+53.27 %) |
Jul 26 2011 | IBPI | Ardea Biosciences, ... | Beck John W | SVP, Finance & Oper ... | Option Exercise | M | 14.26 | 16,000 | 228,160 | 184,000 | |
Jul 26 2011 | IBPI | Ardea Biosciences, ... | Beck John W | SVP, Finance & Oper ... | Sell | S | 24.46 | 16,000 | 391,411 | 4,409 | 20.4 K to 4.4 K (-78.40 %) |
Jul 26 2011 | IBPI | Ardea Biosciences, ... | Beck John W | SVP, Finance & Oper ... | Buy | M | 14.26 | 16,000 | 228,160 | 20,409 | 4.4 K to 20.4 K (+362.89 %) |
Jul 08 2011 | IBPI | Ardea Biosciences, ... | DAVIS STEPHEN | EVP & COO | Sell | S | 25.65 | 700 | 17,957 | 18,651 | 19.4 K to 18.7 K (-3.62 %) |
Jul 08 2011 | IBPI | Ardea Biosciences, ... | DAVIS STEPHEN | EVP & COO | Payment of Exercise | F | 25.33 | 191 | 4,838 | 19,351 | 19.5 K to 19.4 K (-0.98 %) |
Jul 05 2011 | IBPI | Ardea Biosciences, ... | Johnson Craig A | Director | Option Exercise | M | 12.16 | 2,000 | 24,320 | 10,500 | |
Jul 05 2011 | IBPI | Ardea Biosciences, ... | Johnson Craig A | Director | Sell | S | 26.60 | 477 | 12,688 | 0 | 477 to 0 (-100.00 %) |
Jul 05 2011 | IBPI | Ardea Biosciences, ... | Johnson Craig A | Director | Sell | S | 26.13 | 1,523 | 39,801 | 477 | 2 K to 477 (-76.15 %) |
Jul 05 2011 | IBPI | Ardea Biosciences, ... | Johnson Craig A | Director | Buy | M | 12.16 | 2,000 | 24,320 | 2,000 | 0 to 2 K |
Jul 05 2011 | IBPI | Ardea Biosciences, ... | Baker Bros. Capital (GP), LLC | Director | Sell | J | 0.00 | 9,301 | 0 | 126,709 | 136 K to 126.7 K (-6.84 %) |
Jul 05 2011 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | Director | Buy | J | 0.00 | 9,301 | 0 | 4,045,398 | 4 M to 4 M (+0.23 %) |
Jun 06 2011 | IBPI | Ardea Biosciences, ... | DAVIS STEPHEN | EVP & COO | Payment of Exercise | F | 23.94 | 192 | 4,596 | 19,542 | 19.7 K to 19.5 K (-0.97 %) |
Jun 29 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Option Exercise | M | 3.90 | 5,000 | 19,500 | 60,000 | |
Jun 29 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Sell | S | 25.37 | 5,000 | 126,875 | 9,387 | 14.4 K to 9.4 K (-34.75 %) |
Jun 29 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Buy | M | 3.90 | 5,000 | 19,500 | 14,387 | 9.4 K to 14.4 K (+53.27 %) |
Jun 06 2011 | IBPI | Ardea Biosciences, ... | FUCHS HENRY J | Director | Option Exercise | M | 2.76 | 3,000 | 8,280 | 17,975 | |
Jun 06 2011 | IBPI | Ardea Biosciences, ... | FUCHS HENRY J | Director | Sell | S | 24.25 | 3,000 | 72,746 | 10,416 | 13.4 K to 10.4 K (-22.36 %) |
Jun 06 2011 | IBPI | Ardea Biosciences, ... | FUCHS HENRY J | Director | Buy | M | 2.76 | 3,000 | 8,280 | 13,416 | 10.4 K to 13.4 K (+28.80 %) |
Jun 03 2011 | IBPI | Ardea Biosciences, ... | POYHONEN JOHN | Director | Option Exercise | M | 5.85 | 500 | 2,925 | 12,500 | |
Jun 03 2011 | IBPI | Ardea Biosciences, ... | POYHONEN JOHN | Director | Option Exercise | M | 5.85 | 5,000 | 29,250 | 13,000 | |
Jun 03 2011 | IBPI | Ardea Biosciences, ... | POYHONEN JOHN | Director | Sell | S | 24.50 | 500 | 12,250 | 0 | 500 to 0 (-100.00 %) |
Jun 03 2011 | IBPI | Ardea Biosciences, ... | POYHONEN JOHN | Director | Buy | M | 5.85 | 500 | 2,925 | 500 | 0 to 500 |
Jun 03 2011 | IBPI | Ardea Biosciences, ... | POYHONEN JOHN | Director | Sell | S | 24.70 | 5,000 | 123,478 | 0 | 5 K to 0 (-100.00 %) |
Jun 03 2011 | IBPI | Ardea Biosciences, ... | POYHONEN JOHN | Director | Buy | M | 5.85 | 5,000 | 29,250 | 5,000 | 0 to 5 K |
Jun 03 2011 | IBPI | Ardea Biosciences, ... | POYHONEN JOHN | Director | Option Exercise | M | 5.85 | 500 | 2,925 | 12,500 | |
Jun 03 2011 | IBPI | Ardea Biosciences, ... | POYHONEN JOHN | Director | Option Exercise | M | 5.85 | 5,000 | 29,250 | 13,000 | |
Jun 03 2011 | IBPI | Ardea Biosciences, ... | POYHONEN JOHN | Director | Sell | S | 24.50 | 500 | 12,250 | 0 | 500 to 0 (-100.00 %) |
Jun 03 2011 | IBPI | Ardea Biosciences, ... | POYHONEN JOHN | Director | Buy | M | 5.85 | 500 | 2,925 | 500 | 0 to 500 |
Jun 03 2011 | IBPI | Ardea Biosciences, ... | POYHONEN JOHN | Director | Sell | S | 24.70 | 5,000 | 123,478 | 0 | 5 K to 0 (-100.00 %) |
Jun 03 2011 | IBPI | Ardea Biosciences, ... | POYHONEN JOHN | Director | Buy | M | 5.85 | 5,000 | 29,250 | 5,000 | 0 to 5 K |
Jun 01 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Option Exercise | M | 3.90 | 5,000 | 19,500 | 65,000 | |
Jun 01 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Sell | S | 24.83 | 5,000 | 124,173 | 9,387 | 14.4 K to 9.4 K (-34.75 %) |
Jun 01 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Buy | M | 3.90 | 5,000 | 19,500 | 14,387 | 9.4 K to 14.4 K (+53.27 %) |
May 18 2011 | IBPI | Ardea Biosciences, ... | DAVIS STEPHEN | EVP & COO | Sell | S | 26.06 | 100 | 2,606 | 19,734 | 19.8 K to 19.7 K (-0.50 %) |
May 18 2011 | IBPI | Ardea Biosciences, ... | DAVIS STEPHEN | EVP & COO | Sell | S | 25.29 | 235 | 5,942 | 19,834 | 20.1 K to 19.8 K (-1.17 %) |
May 18 2011 | IBPI | Ardea Biosciences, ... | Beck John W | SVP, Finance & Oper ... | Option Exercise | M | 5.85 | 1,000 | 5,850 | 6,250 | |
May 18 2011 | IBPI | Ardea Biosciences, ... | Beck John W | SVP, Finance & Oper ... | Option Exercise | M | 5.85 | 1,500 | 8,775 | 7,250 | |
May 18 2011 | IBPI | Ardea Biosciences, ... | Beck John W | SVP, Finance & Oper ... | Sell | M | 25.00 | 1,000 | 25,000 | 4,409 | 5.4 K to 4.4 K (-18.49 %) |
May 18 2011 | IBPI | Ardea Biosciences, ... | Beck John W | SVP, Finance & Oper ... | Grant | A | 5.85 | 1,000 | 5,850 | 5,409 | 4.4 K to 5.4 K (+22.68 %) |
May 18 2011 | IBPI | Ardea Biosciences, ... | Beck John W | SVP, Finance & Oper ... | Sell | M | 26.04 | 400 | 10,416 | 4,409 | 4.8 K to 4.4 K (-8.32 %) |
May 18 2011 | IBPI | Ardea Biosciences, ... | Beck John W | SVP, Finance & Oper ... | Sell | M | 25.34 | 1,100 | 27,878 | 4,809 | 5.9 K to 4.8 K (-18.62 %) |
May 18 2011 | IBPI | Ardea Biosciences, ... | Beck John W | SVP, Finance & Oper ... | Grant | A | 5.85 | 1,500 | 8,775 | 5,909 | 4.4 K to 5.9 K (+34.02 %) |
May 11 2011 | IBPI | Ardea Biosciences, ... | Quart Barry D | President and CEO | Option Exercise | M | 3.90 | 20,000 | 78,000 | 105,000 | |
May 11 2011 | IBPI | Ardea Biosciences, ... | Quart Barry D | President and CEO | Sell | S | 27.20 | 20,000 | 544,076 | 62,202 | 82.2 K to 62.2 K (-24.33 %) |
May 11 2011 | IBPI | Ardea Biosciences, ... | Quart Barry D | President and CEO | Buy | M | 3.90 | 20,000 | 78,000 | 82,202 | 62.2 K to 82.2 K (+32.15 %) |
May 06 2011 | IBPI | Ardea Biosciences, ... | DAVIS STEPHEN | EVP & COO | Payment of Exercise | F | 27.45 | 190 | 5,216 | 19,623 | 19.8 K to 19.6 K (-0.96 %) |
Apr 29 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Option Exercise | M | 3.90 | 5,000 | 19,500 | 70,000 | |
Apr 29 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Sell | S | 27.80 | 5,000 | 139,022 | 9,044 | 14 K to 9 K (-35.60 %) |
Apr 29 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Buy | M | 3.90 | 5,000 | 19,500 | 14,044 | 9 K to 14 K (+55.29 %) |
Apr 08 2011 | IBPI | Ardea Biosciences, ... | DAVIS STEPHEN | EVP & COO | Sell | S | 28.20 | 3,000 | 84,594 | 19,813 | 22.8 K to 19.8 K (-13.15 %) |
Apr 08 2011 | IBPI | Ardea Biosciences, ... | DAVIS STEPHEN | EVP & COO | Payment of Exercise | F | 28.70 | 2,304 | 66,125 | 22,813 | 25.1 K to 22.8 K (-9.17 %) |
Apr 08 2011 | IBPI | Ardea Biosciences, ... | DIXON WENDY L | Director | Option Exercise | A | 28.70 | 25,000 | 717,500 | 25,000 | |
Mar 01 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Option Exercise | M | 3.90 | 5,000 | 19,500 | 80,000 | |
Mar 01 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Sell | S | 26.50 | 5,000 | 132,483 | 9,044 | 14 K to 9 K (-35.60 %) |
Mar 01 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Buy | M | 3.90 | 5,000 | 19,500 | 14,044 | 9 K to 14 K (+55.29 %) |
Mar 29 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Option Exercise | M | 3.90 | 5,000 | 19,500 | 75,000 | |
Mar 29 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Sell | S | 27.76 | 5,000 | 138,824 | 9,044 | 14 K to 9 K (-35.60 %) |
Mar 29 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Buy | M | 3.90 | 5,000 | 19,500 | 14,044 | 9 K to 14 K (+55.29 %) |
Mar 03 2011 | IBPI | Ardea Biosciences, ... | Hagerty David T | Senior VP & CMO | Option Exercise | A | 26.00 | 150,000 | 3,900,000 | 150,000 | |
Feb 16 2011 | IBPI | Ardea Biosciences, ... | Beck John W | SVP, Finance & Oper ... | Option Exercise | M | 5.85 | 7,500 | 43,875 | 8,750 | |
Feb 16 2011 | IBPI | Ardea Biosciences, ... | Beck John W | SVP, Finance & Oper ... | Sell | M | 26.61 | 7,500 | 199,587 | 4,409 | 11.9 K to 4.4 K (-62.98 %) |
Feb 16 2011 | IBPI | Ardea Biosciences, ... | Beck John W | SVP, Finance & Oper ... | Grant | A | 5.85 | 7,500 | 43,875 | 11,909 | 4.4 K to 11.9 K (+170.11 %) |
Feb 09 2011 | IBPI | Ardea Biosciences, ... | Quart Barry D | President and CEO | Option Exercise | M | 3.90 | 15,000 | 58,500 | 125,000 | |
Feb 09 2011 | IBPI | Ardea Biosciences, ... | Quart Barry D | President and CEO | Option Exercise | M | 3.90 | 20,000 | 78,000 | 140,000 | |
Feb 09 2011 | IBPI | Ardea Biosciences, ... | Quart Barry D | President and CEO | Buy | M | 3.90 | 15,000 | 58,500 | 62,202 | 47.2 K to 62.2 K (+31.78 %) |
Feb 09 2011 | IBPI | Ardea Biosciences, ... | Quart Barry D | President and CEO | Sell | S | 26.77 | 20,000 | 535,352 | 47,202 | 67.2 K to 47.2 K (-29.76 %) |
Feb 09 2011 | IBPI | Ardea Biosciences, ... | Quart Barry D | President and CEO | Buy | M | 3.90 | 20,000 | 78,000 | 67,202 | 47.2 K to 67.2 K (+42.37 %) |
Jan 28 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Option Exercise | M | 3.90 | 5,000 | 19,500 | 85,000 | |
Jan 28 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Sell | S | 27.38 | 5,000 | 136,923 | 9,044 | 14 K to 9 K (-35.60 %) |
Jan 28 2011 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Buy | M | 3.90 | 5,000 | 19,500 | 14,044 | 9 K to 14 K (+55.29 %) |
Jan 24 2011 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Buy | P | 26.00 | 212,000 | 5,512,000 | 3,307,112 | 3.1 M to 3.3 M (+6.85 %) |
Jan 24 2011 | IBPI | Ardea Biosciences, ... | 14159 capital (GP), LLC | Director | Buy | P | 26.00 | 9,815 | 255,190 | 93,282 | 83.5 K to 93.3 K (+11.76 %) |
Jan 05 2011 | IBPI | Ardea Biosciences, ... | TANG KEVIN C | Director | Option Exercise | A | 25.97 | 12,500 | 324,625 | 12,500 | |
Jan 24 2011 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.00 | 355,585 | 9,245,210 | 4,036,097 | 3.7 M to 4 M (+9.66 %) |
Jan 05 2011 | IBPI | Ardea Biosciences, ... | REMINGTON JACK | Director | Option Exercise | A | 25.97 | 12,500 | 324,625 | 12,500 | |
Jan 05 2011 | IBPI | Ardea Biosciences, ... | Johnson Craig A | Director | Option Exercise | A | 25.97 | 12,500 | 324,625 | 12,500 | |
Jan 05 2011 | IBPI | Ardea Biosciences, ... | POYHONEN JOHN | Director | Option Exercise | A | 25.97 | 12,500 | 324,625 | 12,500 | |
Jan 05 2011 | IBPI | Ardea Biosciences, ... | FUCHS HENRY J | Director | Option Exercise | A | 25.97 | 12,500 | 324,625 | 12,500 | |
Jan 04 2011 | IBPI | Ardea Biosciences, ... | BAKER FELIX | Director | Option Exercise | A | 25.97 | 12,500 | 324,625 | 12,500 | |
Dec 30 2010 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Option Exercise | M | 3.90 | 5,000 | 19,500 | 90,000 | |
Dec 30 2010 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Option Exercise | M | 3.90 | 5,000 | 19,500 | 95,000 | |
Dec 30 2010 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Buy | M | 3.90 | 5,000 | 19,500 | 9,044 | 4 K to 9 K (+123.64 %) |
Dec 30 2010 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Sell | S | 26.62 | 5,000 | 133,076 | 4,044 | 9 K to 4 K (-55.29 %) |
Dec 30 2010 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Buy | M | 3.90 | 5,000 | 19,500 | 9,044 | 4 K to 9 K (+123.64 %) |
Dec 16 2010 | IBPI | Ardea Biosciences, ... | Quart Barry D | President and CEO | Option Exercise | A | 23.66 | 150,000 | 3,549,000 | 150,000 | |
Dec 16 2010 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Option Exercise | A | 23.66 | 40,000 | 946,400 | 40,000 | |
Dec 16 2010 | IBPI | Ardea Biosciences, ... | DAVIS STEPHEN | EVP & COO | Option Exercise | A | 23.66 | 80,000 | 1,892,800 | 80,000 | |
Dec 16 2010 | IBPI | Ardea Biosciences, ... | Beck John W | SVP, Finance & Oper ... | Option Exercise | A | 23.66 | 20,000 | 473,200 | 20,000 | |
Dec 10 2010 | IBPI | Ardea Biosciences, ... | Quart Barry D | President and CEO | Option Exercise | M | 3.90 | 10,000 | 39,000 | 160,000 | |
Dec 10 2010 | IBPI | Ardea Biosciences, ... | Quart Barry D | President and CEO | Option Exercise | M | 3.90 | 20,000 | 78,000 | 170,000 | |
Dec 10 2010 | IBPI | Ardea Biosciences, ... | Quart Barry D | President and CEO | Buy | M | 3.90 | 10,000 | 39,000 | 47,202 | 37.2 K to 47.2 K (+26.88 %) |
Dec 10 2010 | IBPI | Ardea Biosciences, ... | Quart Barry D | President and CEO | Sell | S | 21.92 | 20,000 | 438,392 | 37,202 | 57.2 K to 37.2 K (-34.96 %) |
Dec 10 2010 | IBPI | Ardea Biosciences, ... | Quart Barry D | President and CEO | Buy | M | 3.90 | 20,000 | 78,000 | 57,202 | 37.2 K to 57.2 K (+53.76 %) |
Dec 10 2010 | IBPI | Ardea Biosciences, ... | Quart Barry D | President and CEO | Gift | G | 0.00 | 5,000 | 0 | 37,202 | 42.2 K to 37.2 K (-11.85 %) |
Nov 30 2010 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Option Exercise | M | 3.90 | 5,000 | 19,500 | 100,000 | |
Nov 30 2010 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Sell | S | 22.24 | 5,000 | 111,219 | 4,044 | 9 K to 4 K (-55.29 %) |
Nov 30 2010 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Buy | M | 3.90 | 5,000 | 19,500 | 9,044 | 4 K to 9 K (+123.64 %) |
Nov 22 2010 | IBPI | Ardea Biosciences, ... | DAVIS STEPHEN | EVP & COO | Sell | S | 21.92 | 351 | 7,693 | 25,117 | 25.5 K to 25.1 K (-1.38 %) |
Nov 01 2010 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Option Exercise | M | 3.90 | 5,000 | 19,500 | 105,000 | |
Nov 01 2010 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Sell | S | 21.03 | 5,000 | 105,144 | 3,700 | 8.7 K to 3.7 K (-57.47 %) |
Nov 01 2010 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Buy | M | 3.90 | 5,000 | 19,500 | 8,700 | 3.7 K to 8.7 K (+135.14 %) |
Sep 30 2010 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Option Exercise | M | 3.90 | 5,000 | 19,500 | 110,000 | |
Sep 30 2010 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Sell | S | 23.03 | 5,000 | 115,139 | 3,700 | 8.7 K to 3.7 K (-57.47 %) |
Sep 30 2010 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Buy | M | 3.90 | 5,000 | 19,500 | 8,700 | 3.7 K to 8.7 K (+135.14 %) |
Sep 24 2010 | IBPI | Ardea Biosciences, ... | POYHONEN JOHN | Director | Option Exercise | M | 5.85 | 4,000 | 23,400 | 18,000 | |
Sep 24 2010 | IBPI | Ardea Biosciences, ... | POYHONEN JOHN | Director | Sell | S | 23.02 | 4,000 | 92,066 | 0 | 4 K to 0 (-100.00 %) |
Sep 24 2010 | IBPI | Ardea Biosciences, ... | POYHONEN JOHN | Director | Buy | M | 5.85 | 4,000 | 23,400 | 4,000 | 0 to 4 K |
Sep 01 2010 | IBPI | Ardea Biosciences, ... | MANHARD KIMBERLY | SVP, Regulatory & D ... | Option Exercise | M | 3.90 | 5,000 | 19,500 | 115,000 |